| Company Name: |
Nextpeptide Inc |
| Tel: |
+86-0571-81612335 +8613336028439 |
| Email: |
sales@nextpeptide.com |
|
| | m-PEG7-Ms Basic information |
| Product Name: | m-PEG7-Ms | | Synonyms: | m-PEG8-Ms;m-PEG7-Ms;20-methoxy-1-(methylsulfonyl)oxy-3,6,9,12,15,18-hexaoxaeicosane;2-[2-[2-[2-[2-[2-(2-Methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl methanesulfonate;2,5,8,11,14,17,20-Heptaoxadocosan-22-ol, 22-methanesulfonate;m-PEG7-OMs | | CAS: | 477775-57-8 | | MF: | C16H34O10S | | MW: | 418.5 | | EINECS: | | | Product Categories: | | | Mol File: | 477775-57-8.mol |  |
| | m-PEG7-Ms Chemical Properties |
| Boiling point | 507.4±50.0 °C(Predicted) | | density | 1.147±0.06 g/cm3(Predicted) |
| | m-PEG7-Ms Usage And Synthesis |
| Description | m-PEG8-Ms is a PEG linker containing a mesyl group. The mesyl group is a good leaving group for nucleophilic substitution reactions. The hydrophilic PEG spacer increases solubility in aqueous media. | | Uses | m-PEG7-MS is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG7-MS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1]. | | IC 50 | Cleavable Linker; PEGs | | References | [1] Sanxing Sun, et al. Triazolotriazine derivatives as a2a receptor antagonists. WO2020002969A1. |
| | m-PEG7-Ms Preparation Products And Raw materials |
|